MLMaria Jesús Lorenzo

Maria Jesús Lorenzo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria Jesús Lorenzo has a total of 185 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3

    by Marta Olivera Santa-Catalina, Montaña Caballero Bermejo, Ricardo Argent, Juan C. Alonso, Francisco Centeno, María J. Lorenzo


  • Hyperosmotic Stress Induces Tau Proteolysis by Caspase‐3 Activation in SH‐SY5Y Cells

    by Marta Olivera‐Santa Catalina, Montaña Caballero‐Bermejo, Ricardo Argent, Juan C. Alonso, Ana Cuenda, María J. Lorenzo, Francisco Centeno

    Tau is a microtubule‐associated protein implicated in the pathogenesis of Alzheimer's disease and other related tauopathies. In this subset of neurodegenerative disorders, Tau auto‐assembles into insoluble fibrils that accumulate in neurons as paired helical filaments (PHFs), promoting cellular dysfunction and cytotoxic effects. Growing evidence suggests that abnormal post‐translational regulation, mainly hyperphosphorylation and aberrant cleavage, drives Tau to this pathological state. In this work we show that sorbitol‐induced hyperosmotic stress promotes Tau proteolysis in SH‐SY5Y neuroblastoma cells. The appearance of cleaved Tau was preceded by the activation of μ‐calpain, the proteasome system and caspase‐3. Tau proteolysis was completely prevented by caspase‐3 inhibition but unaffected by neither the proteasome system nor μ‐calpain activity blockade. Concomitantly, hyperosmotic stress induced apoptosis in SH‐SY5Y cells, which was efficiently avoided by the inhibition of caspase‐3 activity. Altogether, our results provide the first evidence that Tau protein is susceptible to caspase‐3 proteolysis under hyperosmotic stress and suggest a positive relationship between Tau proteolysis and apoptosis in SH‐SY5Y cells. J. Cell. Biochem. 117: 2781–2790, 2016.


  • Implication of Akt, ERK1/2 and alternative p38MAPK signalling pathways in human colon cancer cell apoptosis induced by green tea EGCG

    by María Isabel Cerezo-Guisado, Rafal Zur, María Jesús Lorenzo, Ana Risco, Miguel A. Martín-Serrano, Alberto Alvarez-Barrientos, Ana Cuenda, Francisco Centeno


  • c-Jun N-terminal protein kinase signalling pathway mediates lovastatin-induced rat brain neuroblast apoptosis

    by Maria Isabel Cerezo-Guisado, Alberto Álvarez-Barrientos, Ricardo Argent, Luis Jesús García-Marín, Maria Julia Bragado, Maria Jesús Lorenzo


  • CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: Intracellular signals after cholecystokinin stimulation

    by Sonja Langmesser, Maria I. Cerezo‐Guisado, Maria J. Lorenzo, Luis J. Garcia‐Marin, Maria J. Bragado

    Cholecystokinin (CCK) is one of the most abundant neuropeptides in the central nervous system (CNS) where it promotes important functions by activation of receptors CCK1 and CCK2. Our aim was to investigate CCK receptors expression and their downstream intracellular signaling in immortalized rat brain neuroblasts. Results show that CCK1 and CCK2 receptor mRNAs and CCK2 receptor protein are expressed in neuroblasts. CCK incubation of neuroblasts leads to stimulation in a time‐dependent manner of several signaling pathways, such as tyrosine phosphorylation of adaptor proteins paxillin and p130Cas, phosphorylation of p44/p42 ERKs as well as PKB (Ser473). Moreover, CCK‐8 stimulates the DNA‐binding activity of the transcription factor AP‐1. The CCK2 receptor agonist gastrin stimulates ERK1/2 phosphorylation in a comparable degree as CCK does. ERK1/2 phosphorylation activated by CCK‐8 was markedly inhibited by the CCK2 receptor antagonist CR2945. Incubation for 48 h with CCK‐8 increases neuroblasts viability in a similar degree as EGF. In summary, our data clearly identify CCK1 and CCK2 receptor mRNAs and CCK2 receptor protein in brain neuroblasts and show that incubation with CCK promotes cell proliferation and activates the phosphorylation of survival transduction pathways. Stimulation of ERK1/2 phosphorylation by CCK is mainly mediated by the CCK2 receptor. Moreover, this work might provide a novel model of proliferating neuronal cells to further study the biochemical mechanisms by which the neuropeptide CCK exerts its actions in the CNS. J. Cell. Biochem. 100: 851–864, 2007.


  • Lovastatin inhibits the extracellular-signal-regulated kinase pathway in immortalized rat brain neuroblasts

    by Maria Isabel Cerezo-Guisado, Natalia García-Román, Luis Jesús García-Marín, Alberto Álvarez-Barrientos, Maria Julia Bragado, Maria Jesús Lorenzo

    We have shown previously that lovastatin, a 3-hydroxy-3-methyl- glutaryl coenzyme A reductase inhibitor, induces apoptosis in spontaneously immortalized rat brain neuroblasts. In the present study, we analysed the intracellular signal transduction pathways by which lovastatin induces neuroblast apoptosis. We showed that lovastatin efficiently inhibited Ras activation, which was associ-ated with a significant decrease in ERK1/2 (extracellular-signal-regulated kinase 1/2) phosphorylation. Lovastatin also decreased CREB phosphorylation and CREB-mediated gene expression. The effects of lovastatin on the Ras/ERK1/2/CREB pathway were time- and concentration-dependent and fully prevented by meva-lonate. In addition, we showed that two MEK [MAPK (mitogen-activated protein kinase)/ERK kinase] inhibitors, PD98059 and PD184352, were poor inducers of apoptosis in serum-treated neuroblasts. However, these inhibitors significantly increased apop-tosis induced by lovastatin treatment. Furthermore, we showed that pharmacological inhibition of both MEK and phosphoinos-itide 3-kinase activities was able to induce neuroblast apoptosis with similar efficacy as lovastatin. Our results suggest that lovast-atin triggers neuroblast apoptosis by regulating several signalling pathways, including the Ras/ERK1/2 pathway. These findings might also contribute to elucidate the intracellular mechanisms involved in the central nervous system side effects associated with statin therapy.


  • Open Access

    Cleavage of focal adhesion proteins and PKCδ during lovastatin‐induced apoptosis in spontaneously immortalized rat brain neuroblasts

    by Lauro González‐Fernández, Maria Isabel Cerezo‐Guisado, Sonja Langmesser, Maria Julia Bragado, Maria Jesús Lorenzo, Luis Jesús García‐Marín

    We have previously shown that lovastatin induces apoptosis in spontaneously immortalized rat brain neuroblasts. Focal adhesion proteins and protein kinase Cδ (PKCδ) have been implicated in the regulation of apoptosis. We found that lovastatin exposure induced focal adhesion kinase, Crk‐associated substrate (p130Cas), PKCδ cleavage and caspase‐3 activation in a concentration‐dependent manner. Lovastatin effects were fully prevented by mevalonate. The cleavage of p130Cas was almost completely inhibited by z‐DEVD‐fmk, a specific caspase‐3 inhibitor, and z‐VAD‐fmk, a broad spectrum caspase inhibitor, indicating that cleavage is mediated by caspase‐3. In contrast, the lovastatin‐induced cleavage of PKCδ was only blocked by z‐VAD‐fmk suggesting that PKCδ cleavage is caspase‐dependent but caspase‐3‐independent. Additionally, z‐VAD‐fmk partially prevented lovastatin‐induced neuroblast apoptosis. The present data show that lovastatin may induce neuroblast apoptosis by both caspase‐dependent and independent pathways. These findings may suggest that the caspase‐dependent component leading to the neuroblast cell death is likely to involve the cleavage of focal adhesion proteins and PKCδ, which may be partially responsible for some biochemical features of neuroblast apoptosis induced by lovastatin.


  • Lovastatin inhibits the growth and survival pathway of phosphoinositide 3‐kinase/protein kinase B in immortalized rat brain neuroblasts

    by Maria Isabel Cerezo‐Guisado, Luis Jesus Garcia‐Marin, Maria Jesus Lorenzo, Maria Julia Bragado

    We previously showed that lovastatin, an HMG‐CoA reductase inhibitor, suppresses cell growth by inducing apoptosis in rat brain neuroblasts. Our aim was to study intracellular signalling induced by lovastatin in neuroblasts. Lovastatin significantly decreases the phosphoinositide 3‐kinase (PI3‐K) activity in a concentration‐dependent manner. Expression of p85 subunit and its association with phosphotyrosine‐containing proteins are unaffected by lovastatin. Lovastatin decreases protein kinase B (PKB)/Akt phosphorylation, and its downstream effectors, p70S6K and the eukaryotic initiation factor 4E (eIF4E) regulatory protein 1, 4E‐BP1, in a concentration‐dependent manner, and reduces p70S6K expression. Lovastatin effects are fully prevented with mevalonate. Only the highest dose of PI3‐K inhibitors that significantly reduce PI3‐K kinase activity induces apoptosis in neuroblasts but to a lower degree than lovastatin. In summary, this work shows that treatment of brain neuroblasts with lovastatin leads to an inhibition of the main pathway that controls cell growth and survival, PI3‐K/PKB and the subsequent blockade of downstream proteins implicated in the regulation of protein synthesis. This work suggests that inactivation of the antiapoptotic PI3‐K appears insufficient to induce the degree of neuroblasts apoptosis provoked by lovastatin, which must necessarily involve other intracellular pathways. These findings might contribute to elucidate the molecular mechanisms of some statins effects in the central nervous system.


  • Lovastatin Induces Apoptosis of Spontaneously Immortalized Rat Brain Neuroblasts: Involvement of Nonsterol Isoprenoid Biosynthesis Inhibition

    by Natalia Garcı́a-Román, Alberto M. Álvarez, Marı́a J. Toro, Agustı́n Montesc, Marı́a J. Lorenzo


  • Open Access

    Exocytotic protein components in rat pituitary gland after long-term estrogen administration

    by G Majo, Mj Lorenzo, J Blasi, F Aguado

    Recently, a set of proteins involved in the docking and fusion machinery of secretory organelles has been identified in anterior pituitary cells. In this study we analyzed, by Western blotting and immunocytochemistry, the expression of several proteins involved in exocytosis after long-term administration of 17beta-estradiol (E2) in Fischer 344 rats. No differences were observed in the amount of synaptosomal-associated protein of 25 kDa, synaptobrevin 2, syntaxin 1, synaptotagmin I and Rab3a in total brain homogenates from treated rats after E2 administration. In striking contrast, the levels of all of these exocytotic proteins, including cellubrevin, were notably decreased in pituitary glands of E2-treated rats. In addition, no differences were observed in the in vitro basal and 8-Br-cAMP-induced prolactin (PRL) release between pituitary cells from control and E2-treated rats, whereas TRH-induced PRL release in anterior pituitary cells from E2-treated animals was higher than in control donors. In conclusion, this study shows that protein components of the exocytotic machinery are specifically down-regulated in the pituitary gland of E2-treated Fischer 344 rats.